APNA Clinical Psychopharmacology Institute
Psychopharmacology Updates Planned for Nurses, by Nurses for More Than 20 Years
Save the Dates!
APNA 22nd Annual Clinical Psychopharmacology Institute
June 6-9, 2024
Bethesda North Marriott Hotel & Conference Center
5701 Marinelli Road
Rockville, MD 20852
This year’s cutting-edge program will feature a range of in-depth presentations on psychopharmacologic topics tailored to psychiatric-mental health nurses, including:
- Updates on how to prescribe and de-prescribe benzodiazepines
- Nutritional psychiatry, including the connection between food, oxidative stress, inflammation, and mood
- The most current perspectives on how it use lithium and its renal effects
- Treatment options and alternatives for when bipolarity complicates diagnosis and treatment of depression
- Best practices in smoking cessation
- How current research translates into new strategies for treatment resistant depression and anxiety, including ECT versus Ketamine
- How precision health care can help prescribers make more personalized medication choices
- Updates in critical treatment considerations for children with suicidal ideation
- Pharmacology and weight management
- Addressing polypharmacy in integrated primary care settings
Session recordings available in the APNA eLearning Center!
Attendees: Check your inbox for a 7/26 email that includes your exclusive access code.
Earn up to 20+ ANCC NCPD Contact Hours in Pharmacology
“CPI was well balanced, with a variety of subjects, information, and research. The speakers were outstanding. I was glad that several speakers brought up different ideas about diagnosis, DSM 5-TR and medication usage. These ideas can lead to thinking deeply about care that is being provided.”
– Pam Marcus, RN, APRN, PMH-BC
Master your psychopharmacologic nursing practice across the lifespan.
The APNA Clinical Psychopharmacology Institute (CPI) delivers psychopharmacology updates to professionals looking to provide the best possible care to their patients. CPI prioritizes the integration of psychopharmacology and neuroscience into clinical practice. It offers the scientific base for treatment decisions and addresses the context of care within the nurse/consumer/family relationship.
Join other providers like you.
The APNA Clinical Psychopharmacology Institute is appropriate for RN-PMH and advanced practice psychiatric nurses (PMH-NP & PMH-CNS) – especially those who administer and/or prescribe medications. Because CPI is planned for nurses, by nurses, the program provides a depth and breadth of scientific information tailored to the challenges inherent in psychiatric-mental health nursing practice. All other health care providers interested in psychopharmacology are welcome for advanced study, especially fellow nurses, primary care physicians, psychiatrists, psychologists, and pharmacists.
The content of this CNE activity pertains to pharmacology. Because states’ requirements may vary, contact your Board of Nursing for more information.
The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.